Bornyl acetate

Catalog No.S3893 Batch:S389302

Print

Technical Data

Formula

C12H20O2
Molecular Weight 196.29 CAS No. 76-49-3
Solubility (25°C)* In vitro DMSO 39 mg/mL (198.68 mM)
Ethanol 39 mg/mL (198.68 mM)
Water Insoluble
In vivo (Add solvents to the product individually and in order)
Clear solution
5%DMSO 40%PEG300 5%Tween80 50%ddH2O
1.95mg/ml Taking the 1 mL working solution as an example, add 50 μL of 39 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
Clear solution
5% DMSO 95% Corn oil
1.95mg/ml Taking the 1 mL working solution as an example, add 50 μL of 39 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description Bornyl acetate (Isobornyl, Bornyl acetic ether, 2-Camphanol), the main volatile constituent in numerous conifer oils and some Chinese traditional herbs, exhibits anti-inflammatory property and it is used as an analgesic.
In vitro Bornyl acetate induces dose-dependent growth inhibitory effects on human gastric cancer cells in vitro. Bornyl acetate potentiates the anticancer activity of 5-FU in human gastric cancer (SGC-7901) cells by inducing apoptosis, DNA fragmentation as well as G2/M cell cycle arrest[2].
In vivo Bornyl acetate downregulates the levels of proinflammatory cytokines in vitro and in vivo; reduces the number of total cells, neutrophils, and macrophages in BALF; attenuates the histologic alterations in the lung; decreases the wet-to-dry weight ratio in BALF; and suppresses NF-kappa-B inhibitor alpha, extracellular regulated protein kinases, c-JunN-terminal kinase, p38 mitogen-activated protein kinase activation[1].
Density 0.985 g/mL at 25 °C

Protocol (from reference)

Cell Assay:[1]
  • Cell lines

    RAW 264.7 cells.

  • Concentrations

    0-500 μg/mL

  • Incubation Time

    18 h

  • Method

    RAW 264.7 cells are cultured with bornyl acetate (0-500 μg/mL) in the absence or presence of LPS (1 mg/L) for 18 h. Cell viability is assessed by MTT reduction assays.
Animal Study:[1]
  • Animal Models

    BALB/c mice

  • Dosages

    25, 50, and 100mg/kg

  • Administration

    i.p.

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.